SOM Biotech announces the appointment of Alain Duguet Ph.D. as Head of Chemical Manufacturing and Control.
Leer másThe virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportuni...
Leer másSOM Biotech will participate in the Euronext webinar “Finance your tech company´s growth through capital markets” next June 25th.
Leer másSOM Biotech will attend BIO International Convention 2020 in its virtual format “BIO Digital” on June 8th – 12th.
Leer másSOM Biotech reoriented its capabilities to search for the treatments of COVID-19. Raúl Insa, CEO of SOM Biotech, acknowledges that he had never thought of using his technology to find treatment fo...
Leer másInterested in learning more about the role of Artificial Intelligence in Healthcare?
Leer másSOM Biotech, compañía biotecnológica para el desarrollo y descubrimiento de fármacos, anuncia la validación in vitro de tres candidatos a fármacos como nuevas terapias para el tratamiento del...
Leer másWhile the coronavirus outbreak grows worldwide, at SOM Biotech we continue working on our pipeline to bring therapies for patients with rare diseases.
Leer másSOM Biotech will attend the Eyeforpharma Barcelona event that will be hosted online due to the impact of COVID-19, between March 31st and April 2nd 2020.
Leer másThe Rare Disease Day event will be focused on expert discussion tables chaired by the Catalan Health Department dedicated to sharing testimonies of affected patients and families.
Leer másSOM Biotech, compañía biofarmacéutica para la identificación, desarrollo - en fase preclínica y clínica – y comercialización de fármacos para el tratamiento de enfermedades huérfanas, princ...
Leer másSOM Biotech cierra una ronda de financiación de 7 millones de euros
Leer más